Amicus Therapeutics
![Amicus Seals $430M Financing from Blackstone Post-Pompe Disease Drug Approval](https://pharmtales.com/wp-content/uploads/2023/10/Amicus-Seals-430M-Financing-from-Blackstone-Post-Pompe-Disease-Drug-Approval.jpg)
Amicus Seals $430M Financing from Blackstone Post-Pompe Disease Drug Approval
Anika Sharma
Fresh from securing FDA approval for its combination treatment targeting Pompe disease, Amicus Therapeutics has attracted a significant investment. Amicus ...